Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine

This vaccine protects against five major serogroups of Neisseria meningitidis—A, C, Y, W, and X—responsible for life-threatening bacterial meningitis and septicemia. It contains polysaccharide antigens conjugated to a carrier protein to stimulate a robust immune response. Recommended for children, adolescents, travelers to endemic areas, and outbreak control, it is administered intramuscularly. Conjugation allows long-lasting protection and immunological memory, making it more effective than plain polysaccharide vaccines. It's crucial in preventing outbreaks, especially in the "meningitis belt" of sub-Saharan Africa.